The expanding interest in small bioactive peptides has brought renewed attention to glycyl-L-histidyl-L-lysine bound to ...

Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.

The etiology of the progressive neurodegeneration that characterizes Parkinson’s disease (PD) remains relatively enigmatic, despite immense advances in our ...